Inventor · disambiguated record
Carmelo Romano
Also filed as: ROMANO CARMELO
14 granted patents·17 pending applications·53 citations·filing 1980–2025
88Inventor score
Files withREGENERON PHARMA24ALCON RES LTD1ALNYLAM PHARMACEUTICALS INC1AZAR JOSEPH1KAZLAUSKAS ANDRIUS1
Top patents by PatentIndex Score
31 records- 0195US10633434B2Anti-C5 antibodiesREGENERON PHARMA·Filed 2017·Granted Apr 28, 2020·20 cites·18 claims
- 0284US11492392B2Polynucleotides encoding anti-C5 antibodiesREGENERON PHARMA·Filed 2020·Granted Nov 8, 2022·1 cites·23 claims
- 0383US11479602B2Methods of treating C5-associated diseases comprising administering anti-C5 antibodiesREGENERON PHARMA·Filed 2020·Granted Oct 25, 2022·1 cites·23 claims
- 0479US11064685B2Non-human animal models of retinoschisisREGENERAN PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·1 cites·29 claims
- 0578US2023174631A1Anti-c5 antibodies and uses thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0676US11419318B2Genetically modified rat comprising a humanized TRKB locusREGENERON PHARMA·Filed 2018·Granted Aug 23, 2022·1 cites·9 claims
- 0774US2024148774A1Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0871US12396444B2Mouse comprising a humanized TRKB locusREGENERON PHARMA·Filed 2022·Granted Aug 26, 2025·0 cites·14 claims
- 0970US12082565B2Non-human animals models of retinoschisisREGENERON PHARMA·Filed 2021·Granted Sep 10, 2024·0 cites·26 claims
- 1070US11865134B2Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 1170US4319760AOccupant propelled skateboardAZAR JOSEPH·Filed 1980·Granted Mar 16, 1982·28 cites·7 claims
- 1268US2025115918A1Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1365US12370257B2Materials and methods of treating MHC-I-opathy risk haplotypesREGENERON PHARMA·Filed 2022·Granted Jul 29, 2025·0 cites·13 claims
- 1462US12157891B2Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitorsREGENERON PHARMA·Filed 2022·Granted Dec 3, 2024·0 cites·9 claims
- 1562US11767526B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Sep 26, 2023·0 cites·11 claims
- 1662US2025375519A1Materials And Methods Of Treating MHC-1-Opathy Risk HaplotypesREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1760US2023405238A1Systems and methods for drug delivery to ocular tissueREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1859US2024238384A1Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1958US8722015B2Compositions and methods for treatment of angiogenesis-associated ocular disordersKAZLAUSKAS ANDRIUS·Filed 2011·Granted May 13, 2014·1 cites·6 claims
- 2058US2024409943A1iRNA Compositions and Methods for Targeting ANGPTL7ALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2158US2025143922A1Systems and methods for drug delivery to ocular tissueREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2256US11845989B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Dec 19, 2023·0 cites·4 claims
- 2351US2022331241A1Treatment of x-linked juvenile retinoschisisREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 2451US2009012030A1RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATIONALCON RES LTD·Filed 2008·Application pending·0 cites
- 2550US2022089664A1Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2647US2023059929A1Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune ResponseREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2745US2008269318A1Treatment of age-related macular degeneration using inhibitors of complement factor dROMANO CARMELO·Filed 2008·Application pending·0 cites
- 2843US2022047618A1Adeno-associated virus vectors for the delivery of therapeuticsREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 2942US2016152717A1Methods for treating dry eye disease by administering an il-6r antagonistREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 3037US2012004245A1Compounds for the treatment of posterior segment disorders and diseasesMAY JESSE A·Filed 2011·Application pending·0 cites
- 3135US2017360013A1Animal model for dry eye and methods of use of such animalsREGENERON PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carmelo Romano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →